资讯

FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
Express Healthcare4 小时
FDA approves first blood test to support Alzheimer’s diagnosis
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...
FDA clears 1st blood test to help diagnose Alzheimer's disease
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
pharmaphorum11 小时
FDA clears first blood test for Alzheimer's disease
The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward ...
InsideHook on MSN12 小时
The FDA Just Approved an Alzheimer's Disease Blood Test
If you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...
Medical Dialogues17 小时
FDA Approves First Blood Test for Alzheimer's Diagnosis
The FDA has cleared first blood-based in vitro diagnostic tool for detecting Alzheimer’s disease. It is approved for use in ...
MyChesCo on MSN19 小时
Groundbreaking Blood Test Offers New Hope for Alzheimer’s Diagnosis
The U.S. Food and Drug Administration (FDA) has cleared a first-of-its-kind blood test designed to aid in the diagnosis of ...
Egypt Independent22 小时
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...